Annual report [Section 13 and 15(d), not S-K Item 405]

Supplemental Balance Sheet and Cash Flow Information

v3.26.1
Supplemental Balance Sheet and Cash Flow Information
12 Months Ended
Jun. 30, 2026
Notes to Financial Statements  
Supplemental Balance Sheet and Cash Flow Information

Note 3. Supplemental Balance Sheet and Cash Flow Information:

Inventories:

Inventories consist of (in thousands):

​

​

​

​

​

​

​

​

​

June 30, 

​

​

2026

  ​ ​ ​

2025

Raw materials

​

$

90,275

​

$

89,080

Finished goods(1)

​

 

111,811

​

 

106,188

Inventories

​

$

202,086

​

$

195,268

(1) Finished goods inventory of $6,342 and $5,822 is included within Other assets in the June 30, 2026 and 2025 Consolidated Balance Sheets, respectively, as it is forecasted to be sold after the 12 months subsequent to the Consolidated Balance Sheets dates.

Property and Equipment:

Property and equipment consist of (in thousands):

​

​

​

​

​

​

​

​

  ​ ​ ​

June 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Land

​

$

8,113

​

$

8,151

Buildings and improvements

​

 

259,688

​

 

254,355

Machinery and equipment

​

​

254,844

​

 

245,924

Construction in progress

​

 

17,445

​

​

23,420

Property and equipment, cost

​

 

540,090

​

 

531,850

Accumulated depreciation and amortization

​

 

(308,254)

​

 

(286,131)

Property and equipment, net

​

$

231,836

​

$

245,719

​

Depreciation expense was $36.2 million, $34.6 million, and $31.9 million in fiscal 2026, 2025, and 2024, respectively.

Intangible assets were comprised of the following (in thousands):

​

​

​

​

​

​

​

​

​

​

Useful Life

June 30, 

​

​

(years)

2026

​

2025

Developed technology

 

9 - 15

$

578,310

​

$

620,062

Tradenames

 

2 - 20

 

94,175

​

 

152,648

Customer relationships

 

7 - 16

 

210,004

​

 

212,800

Patents

 

10

 

5,559

​

 

4,967

Other intangibles

 

5 - 15

 

7,139

​

 

7,174

Definite-lived intangible assets

​

​

 

895,187

​

 

997,651

Accumulated amortization

​

​

 

(591,722)

​

 

(632,052)

Total intangible assets, net

​

​

$

303,465

​

$

365,599

​

Changes to the carrying amount of net intangible assets consist of (in thousands):

​

​

​

​

​

​

​

​

  ​ ​ ​

June 30, 

​

​

2026

​

2025

Beginning balance

​

$

365,599

​

$

507,081

Other additions

​

 

594

​

 

547

Amortization expense

​

​

(61,788)

​

​

(76,043)

Restructuring impairment(1)

​

​

—

​

​

(73,350)

Currency translation

​

​

(940)

​

​

7,364

Ending balance

​

$

303,465

​

$

365,599

(1) Refer to Note 14 for further detail on held-for-sale intangibles.

Amortization expense related to developed technologies included in Cost of sales was $37.8 million, $44.0 million, and $46.6 million in fiscal 2026, 2025, and 2024, respectively. Amortization expense related to trade names, customer relationships, non-compete agreements, and patents included in Selling, general and administrative expense was $23.4 million, $31.3 million, and $33.2 million, in fiscal 2026, 2025, and 2024, respectively.

The estimated future amortization expense for intangible assets as of June 30, 2026 is as follows (in thousands):

​

​

​

​

2027

  ​ ​ ​

$

58,627

2028

​

 

54,899

2029

​

 

40,837

2030

​

 

26,878

2031

​

 

23,986

Thereafter

​

 

98,238

Total

​

$

303,465

​

​

Goodwill:

​

Changes in goodwill by segment and in total consist of (in thousands):

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Diagnostics and

  ​ ​ ​

​

​

​

Protein Sciences

​

 Spatial Biology

​

Total

June 30, 2024

  ​ ​ ​

$

423,449

​

$

549,214

​

$

972,663

Held-for-sale goodwill(1)

​

​

—

​

​

(4,488)

​

​

(4,488)

Currency translation

​

 

3,327

​

​

9,433

​

 

12,760

June 30, 2025

​

$

426,776

​

$

554,159

​

$

980,935

Currency translation

​

 

(3,781)

​

​

(1,799)

​

​

(5,580)

June 30, 2026

​

$

422,995

​

$

552,360

​

$

975,355

(1) Refer to Note 14 for further detail on goodwill reclassified to current assets held-for-sale.

Other Assets:

​

Other assets consist of (in thousands):

​

​

​

​

​

​

​

​

​

  ​ ​ ​

June 30, 

​

  ​ ​ ​

2026

​

2025

Equity method investment in Wilson Wolf

​

$

230,827

​

$

235,983

Long-term inventory

​

​

6,342

​

​

5,822

Investment in Spear Bio

​

​

15,000

​

​

15,000

Notes receivable(1)

​

​

7,560

​

​

2,184

Other

​

 

4,607

​

 

24,927

Other assets

​

$

264,336

​

$

283,916

(1) Amounts relate to the divestiture of our businesses held-for-sale.

​

Supplemental Cash Flow Information:

Supplemental cash flow information is as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Year Ended June 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2024

Income taxes paid

​

$

64,149

​

$

74,357

​

$

65,254

Interest paid

​

 

14,395

​

 

18,955

​

 

14,502

​